Delivery Order SPE2DB22D2211-SPE2DB25FSFGR
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens in 0.5 mL units. This firm fixed-price delivery order, valued at $1,088.36, is scheduled for completion by September 2, 2025, and represents a non-competitive set-aside award. The order will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,448.81 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion by July 15, 2025, with performance taking place at the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. The contract, valued at $20,199.71, is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. This award was made on a competitive basis with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,786.43 by the Defense Logistics Agency on September 18, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml). This competitive, firm fixed-price delivery order is non-set-aside and is scheduled for completion by September 19, 2025, with performance taking place at the company's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,619.20 by the Defense Logistics Agency on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, which carries an ultimate completion date of July 21, 2025, represents a non-competitive set-aside transaction and will be performed at the company's Corporate Office location in Conshohocken, PA....
- The Defense Logistics Agency awarded a delivery order valued at $2,796.54 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $48,976.20 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies performance at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,537.17 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections with an ultimate completion date of September 4, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under...
- The Defense Logistics Agency awarded a $2,448.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units). The contract is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $1,597.14 and an ultimate completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under open competition. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFGRDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,162.70 by the Defense Logistics Agency on September 18, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed by September 19, 2025, with the place of performance located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Mounjaro delivery represents a diabetes medication fulfillment as part of the company's extensive portfolio of pharmaceutical products supporting federal medical procurement needs for the Defense Health Agency and related military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 9/18/25 |